Genetic studies of autism over the past decade suggest a complex landscape of multiple genes. In the face of this heterogeneity, studies that include large extended pedigrees may offer valuable insights, as the relatively few susceptibility genes within single large families may be more easily discerned. This genome-wide screen of 70 families includes 20 large extended pedigrees of 6-9 generations, 6 moderate-sized families of 4-5 generations and 44 smaller families of 2-3 generations. The Center for Inherited Disease Research (CIDR) provided genotyping using the Illumina Linkage Panel 12, a 6K single-nucleotide polymorphism (SNP) platform. Results from 192 subjects with an autism spectrum disorder (ASD) and 461 of their relatives revealed genome-wide significance on chromosome 15q, with three possibly distinct peaks: 15q13.1-q14 (heterogeneity LOD (HLOD) = 4.09 at 29 459 872 bp); 15q14-q21.1 (HLOD = 3.59 at 36 837 208 bp); and 15q21.1-q22.2 (HLOD = 5.31 at 55 629 733 bp). Two of these peaks replicate earlier findings. There were additional suggestive results on chromosomes 2p25.3-p24.1 (HLOD = 1.87), 7q31.31-q32.3 (HLOD = 1.97) and 13q12.11-q12.3 (HLOD = 1.93). Affected subjects in families supporting the linkage peaks found in this study did not reveal strong evidence for distinct phenotypic subgroups.
Introduction
Autism spectrum disorders (ASDs; MIM 209850) are characterized by impairments in social interaction and communication as well as by repetitive and stereotyped behaviors and interests. ASDs include autistic disorder, Asperger disorder and pervasive developmental disorder-not otherwise specified (PDD-NOS). Prevalence estimates for ASDs have recently been reported to be approximately 1 in every 150 children in the general population. 1 In families with an autistic child, recurrence rates are estimated to be greater than 15% that an additional offspring will also have autism. 2, 3 ASDs present a serious public health concern that warrants identification of risk factors with great urgency.
Genetic factors play a substantial role in ASDs (see Abrahams and Geschwind 4 ). However, recent gene discovery efforts for ASDs show that genetic heterogeneity is the rule, rather than the exception. Although known genes now explain as much as 20% of ASD cases, each known genetic cause explains only a small fraction of the total. 4 In addition, genome-wide linkage and association studies conducted over the past decade have implicated multiple regions. Such heterogeneity increases the value of studies that include large extended pedigrees. Many autism studies have focused on small families (sibling pairs, or two parents and an affected offspring) to try to localize autism predisposition genes. These collections of small families may include cases with many different susceptibility loci. Subjects affected with ASDs who are members of a large extended family may be more likely to share the same genetic causes through their common ancestors. Within such families, autism may be more genetically homogeneous. 5, 6 In addition, these family members are more likely to share similar environmental exposures, facilitating possible future analyses of gene-byenvironment interaction effects.
We recently published a genome-wide, 10K singlenucleotide polymorphism (SNP) linkage analysis using one of the largest known extended ASD pedigrees, with seven ASD cases distributed in a six-generation pedigree, all of whom were descendents of a single founding couple. 7 In this earlier study, we identified three chromosomal regions meeting genome-wide linkage significance criteria at 3q13.2-13.31, 3q26.31-q27.3 and 20q11.21-q13.12, and two additional regions meeting criteria for suggestive significance at 7p14.1-p11. 22 and 9p24.3. All five identified regions replicated earlier findings, and for some of the regions, we were able to narrow the boundaries. However, our results again illustrated the complex nature of ASD as we found genetic heterogeneity even within a single pedigree.
In this study, we present genome-wide 6K SNP linkage results for 70 multiple-generation pedigrees, ranging in size from six to nine generations. Ascertainment of these 70 multigeneration pedigrees represents over 20 years of autism research in Utah. 8 These pedigrees show modest positive scores in two of our earlier identified regions (9p24.3 and 20q11.21-q13.12), and provide convincing evidence for new ASD susceptibility loci on chromosome 15.
Materials and methods

Subjects
Subjects were members of 70 pedigrees having at least two family members with an ASD. A total of 653 subjects were genotyped, 192 of whom were defined as having either a strictly defined autistic disorder or a more broadly defined ASD (Table 1) . Table 1 shows the characteristics of these families, which include 20 large extended pedigrees of 6-9 generations, 6 moderately sized families of 4-5 generations and 44 smaller families of 2-3 generations. The 20 extended pedigrees have an average of 23 deceased connecting relatives in the upper generations who were not genotyped. These families were identified or confirmed using the Utah Population Database (UPDB), a computerized genealogy database that contains family history information for over 6.5 million individuals who are, for the most part, descendants of the nineteenth century Utah pioneers (www.hci.utah. edu/groups/ppr/). Earlier studies have shown low rates of inbreeding within the Utah Population Database. 9, 10 Using the Utah Population Database, we were able to identify many distant family relationships between the individuals with ASD that were not known to the subjects or their families. These relationships were kept confidential. This study has ongoing approval from the University of Utah Institutional Review Board.
Phenotyping
Families interested in participating were asked to give questionnaire consent, then to give initial information regarding possible exclusion criteria and to complete the Social Communication Questionnaire (SCQ). 11 The SCQ was developed as a parent report measure based on the Autism Diagnostic Interview-Revised (ADI-R). 12 A cutoff score of 15 on the SCQ has been shown to have good sensitivity (0.85) and specificity (0.75) for identifying ASDs from other diagnoses. 11, 13 Subjects were contacted for possible inclusion if their SCQ score was above 15, or if they had an earlier diagnosis of ASD. Subjects were excluded if they reported medical conditions known to be associated with autism (tuberous sclerosis, Fragile X, neurofibromatosis, congenital rubella or phenylketonuria) or an evidence of brain injury. If subjects were eligible for the study, they were asked to sign informed consent for DNA and additional assessments. When possible, all subjects with a suspected ASD were then given both ADI-R 12 and the Autism Diagnostic Observation Schedule-Generic (ADOS-G), 14 and study diagnoses were made using these assessments. For cases in which assessments could not be obtained, diagnoses were made according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria by a psychologist trained in autism assessment (JM) using all available information (clinical records, other behavioral data, other questionnaire and interview information). Items from the ADI ('age of first words' and 'age of first phrases') were used to assess language delay. For parents who indicated normal onset, but who could not remember exact ages, values were set to 23 months for words and 32 months for phrases (acquiring language after these ages is considered abnormal on the ADI-R). For parents who indicated delayed onset, but could not remember exact ages, values were set to 1 s.d. above the mean. For subjects who never acquired language, values were set to 3 s.d. above the mean. Qualitative language delay was coded for any subject whose onset was X24 months for words, or X33 months for phrases.
Intelligence Quotient (IQ) was measured in subjects with ASDs using assessments appropriate for age and developmental level. The Wechsler Intelligence Scale for Children (WISC)-III or Wechsler Adult Intelligence Scale (WAIS)-III, 15, 16 Differential Abilities Scale (DAS), 17 and the Mullen Scales of Early Development 18 were used. The DAS is appropriate for children aged 2-1/2 to 18 years with either typical or delayed development, and the General Conceptual Ability Score from the Differential Abilities Scale correlates well with the Full-Scale IQ score of the Wechsler (WISC-III and WAIS-III) scales. 19, 20 If we were unable to obtain a valid score on a subject under 68 months on the Differential Abilities Scale, we used the Mullen, a standardized measure of cognitive function in young children. For those administered the Mullen, the Early Learning Composite t-score (mean = 50, s.d. = 10) was converted to a standard score (mean = 100, s.d. = 15) as a measure of overall IQ. 21 Genotyping Genotyping services were provided by the Center for Inherited Disease Research (CIDR) using the 6 K SNP linkage panel. Originally, 703 samples from the pedigrees were sent for genotyping, in addition to 32 blind duplicates of these pedigree samples for QC, for a total of 735 samples. QC genotyping also included internal controls used by the CIDR. The genotyping platform was the Illumina Linkage Panel 12 (San Diego, CA, USA), which includes 6090 SNP markers, with an average genetic coverage of 0.65 cM. Illumina BeadStudio software (San Diego, CA, USA) was used to evaluate all genotypes using the quantitative GenCall score, which is an indicator of how well a DNA sample performed over all released SNP assays. A total of 55 samples were not released because of one or more of the following reasons: (1) poorly defined clusters, (2) excessive replicate and/or Mendelian errors, (3) more than 50% missing data or (4) a higher-than-expected missing data rate for markers on the X chromosome, suggesting a possible mosaic 46XX or 46XO karaotype. Five of these 55 unreleased samples were blind duplicate pairs and the rest were pedigree subjects. There were, therefore, a total of 680 successfully genotyped subjects, of which 653 were pedigree members and 27 were blind duplicates for QC. Three of the smaller families were left with only one affected case after this QC step, so there were effectively 67 informative families in the sample. Of the 6090 total SNPs possible, 6044 were released. Loci were dropped if atypical clustering patterns were found. A total of 4 309 372 genotypes were released with a missing data rate of 0.064% and a Mendelian consistency rate of 99.96%. SNPs with Mendelian errors were subsequently zeroed using PedCheck (http://watson.hgen.pitt.edu/register). 22 The 27 blind duplicate pairs were checked for consistency between pairs using the file cleaned by PedCheck. Within these cleaned genotypes, duplicate reproducibility was 100%.
Analyses
We used the genetic map provided by the CIDR based on the deCODE (Reykjavik, Iceland) genetic map. 23 Base-pair positions were obtained from the March 2006 human reference sequence (hg18) assembly. Analysis was conducted using the multipoint linkage software MCLINK, a Markov chain Monte Carlo (MCMC) method that allows for multilocus linkage analysis on large extended pedigrees. 24 Using blocked Gibbs sampling, MCLINK generates inheritance matrices from haplotype chains for the markers being analyzed and performs an approximate calculation of the log-likelihood function linkage statistics. Internally, MCLINK runs the analysis five times to ensure a consistent solution. MCLINK has been used earlier to identify candidate genomic regions for a number of complex diseases. 25, 26 Allele frequencies for the MCLINK analysis were estimated using all of the observed data.
We performed a nonparametric analysis and a general parametric model-based analysis using simple dominant and recessive model parameters that reproduced the reported population frequency of ASDs. 1 For the recessive analysis, the disease allele frequency was set at 0.05, with penetrances for each of the three genotypes of 0.0014, 0.0014 and 0.8. For the dominant analysis, the disease allele frequency was set at 0.0025, with penetrances of 0.0014, 0.8 and 0.8. Only affected cases were assumed to have known phenotypes. Although nonparametric methods provide a standard analytic approach for complex psychiatric disorders, the parametric approach is well suited to the analysis of a complex trait such as autism, particularly when using large extended pedigrees. Parametric models, which provide assumptions about the genotype-phenotype relationship, simplify the parameter space and allow for more powerful and efficient analyses without leading to false-positive results. [27] [28] [29] The multipoint heterogeneity LOD (HLOD) score allows for unlinked pedigrees and variation in the recombination fraction. The HLOD provided by MCLINK is robust to model misspecification, and may reflect the true position of linkage peaks more accurately under conditions of appreciable heterogeneity (as is the case with ASD). 26, 28, 30 HLOD scores have been shown to be more powerful than homogeneity LOD scores or model-free methods under these conditions. 31, 32 The HLOD has been shown to produce scores consistent with other published methods. 33, 34 Eliminating linkage disequilibrium (LD) between markers in linkage studies has been strongly recommended, as false-positive results can occur in the presence of LD. [35] [36] [37] [38] [39] As these studies have shown, increases in type I error are most dramatic when LD is high and when there are missing genotypes for parents and other connecting relatives. Recommended thresholds of acceptable LD vary, but a pairwise r 2 value of 0.05 between SNPs has now been supported with extensive simulation studies. 37 Linkage peaks achieving at least suggestive linkage evidence (HLODX1.86) were re-analyzed after screening for LD. SNPs within a 1-LOD drop of each peak were screened using the PLINK software package (http://pngu.mgh.harvard.edu/purcell/plink), 40 which recursively removes SNPs within a sliding window. We set a window size of 50 SNPs, shifted the window by 5 SNPs at each step and used a Variance Inflation Factor of 1.5, which is equivalent to a multiple correlation coefficient R 2 of 0.33 regressed simultaneously over all SNPs in the selected window. This R 2 considers not only the correlations between SNPs but also the linear combinations of SNPs 40 and corresponds in our data to a pair-wise r 2 of approximately 0.05. Also, as part of the validation procedure, we removed rare SNPs with a minor allele frequency less than 0.10. Our screening deleted 63 of the 209 SNPs across all 10 of the re-analyzed regions. Only four SNPs within these screened regions had a pair-wise r 2 > 0.05; the maximum pair-wise r 2 was 0.165. We also checked for SNPs out of Hardy-Weinberg equilibrium using PLINK, and one additional SNP was deleted for this reason. Table 2 describes the diagnostic information for affected subjects. Of the 192 total affected subjects, 166 had data on both ADI-R and ADOS-G. Of these 166 subjects with complete information, 122 met criteria for strictly defined autistic disorder on both assessments, and 44 met criteria for an ASD, having closely missed the cutoff scores for strictly defined autism on one or both measures. The other 27 cases were missing one (N = 22) or both (N = 5) assessments due to testing difficulties and/or unavailability of a reliable informant. There was a 6.7:1 male/female ratio among the subjects with strictly defined autism, which fell to 3.3:1 among the subjects with an ASD. For all subjects combined, the male/female ratio was 5.4:1. Subjects with ASDs were older than subjects with strictly defined autism at entry into the study (mean age: 15.9 vs 12.0 years), though the difference was not significant (t = 1.74, P = 0.09). As expected, ADI-R scores were significantly higher for the autism group compared with those for the ASD group (t = 9.78, P < 0.0001 for social; t = 8.30, P < 0.0001 for verbal; t = 3.86, P = 0.0002 for restricted interests/ repetitive behaviors). The nonverbal total cannot be compared because whereas 28 autistic subjects were nonverbal, only one ASD subject was nonverbal. Means of ADI items indicating delay of first words and phrases also differed by diagnostic group in the expected direction (76.23% in autism vs 52.38% in ASD; P = 0.003). Quantitative scores on the ADOS are not compared because of differences between modules, but more individuals in the autism group were administered modules 1 and 2 compared with that in the ASD group. IQ was obtained for 172 of the 192 affected subjects. Of these, 112 (65.12%) had an IQ > 70. Not surprisingly, significantly fewer subjects with strictly defined autism had an IQ > 70 (57.14%) compared with the percentage of ASD subjects with an IQ > 70 (86.96%; P < 0.0001). Figure 1 shows genome-wide linkage results, and Table 3 gives scores for regions with at least suggestive evidence for linkage (HLODX1.86). 41 Each of these regions was screened for possible inflation due to LD as described above. Significant evidence of Abbreviations: ADOS, Autism Diagnostic Observation Schedule; ASD, autism spectrum disorder.
Results
Note: Of the 140 subjects with autism, 122 had both ADI and ADOS; the 13 who were missing ADI and 7 who were missing ADOS were diagnosed with autism using DSM-IV criteria. Of the 52 subjects with an ASD, 44 had both ADOS and ADI; the 8 who were missing ADI and 6 who were missing ADOS were diagnosed with an ASD using DSM-IV criteria. linkage (HLODX3.3) 41 was found on chromosome 15, and initially on chromosome 21, though the chromosome 21 peak vanished when SNPs were eliminated because of LD. There were 10 closely spaced SNPs within this region that were deleted in the LD screen. The chromosome 15 scores in Table 3 represent three possibly distinct regions, as shown in more detail in Figure 2 . It is worth noting that the scores between these three maxima do not drop substantially. Using a 1-LOD drop to define regions, the approximate boundaries of these three regions are 27 440 000-32 790 000 bp; 32 790 000-43 260 000 bp; and 50 770 000-56 800 000 bp. Nonparametric evidence was also found in these regions. It is worth noting that linkage evidence was provided by multiple pedigrees, both large and small. Maximum scores for individual large pedigrees were not large enough to suggest complete sharing across all affected cases within any pedigree. In fact, the highest score for an individual pedigree within the three chromosome 15 peaks was an LOD of 2.27 under the 15q21.1-q22.2 peak in a seven-generation family with nine affected cases.
We investigated the characteristics of the autism phenotype for cases in the families supporting the three chromosome 15 linkage peaks in our sample. For the pedigrees that achieved nominal point-wise significance (that is, LOD > 0.588 for an individual pedigree, P = 0.05) within the three peaks, the proportion of cases with ASD diagnoses was 30.0, 31.0 and 25.5%, respectively, not significantly different from the overall proportion of autism cases in the entire sample (27.1%) . Similarly, the proportion of maleaffected pedigree members was 75.0, 79.3 and 82.4%, not significantly different from the overall total male percentage of 84.4%. The proportion of affected subjects with an IQ > 70 was 66.7, 65.2 and 54.6%, not significantly different from the overall proportion of 65.1%. Subjects supporting these peaks also did not show significant differences in quantitative means of ADI domain scores or in language delay as measured by the ADI as compared with the full sample. See Supplementary Table 1 for a summary of these results.
As shown in Table 3 and Figure 2 , regions of interest were also initially found on chromosomes 2, 6, 7, 13, 19 and 21. Suggestive linkage evidence was observed on chromosome 2p25.3-p24.1, from about 2 960 000 bp to about 10 660 000 bp that remained after LD screening. We again tested for phenotypic differences among affected subjects in families supporting this peak. No differences were found for gender, ADI scores, language delay or IQ > 70 (see Supplementary  Table 1 ). However, most of the affected subjects in these families had autistic disorder, with significantly fewer affected ASD subjects than observed in the full sample (1/23 = 4.35% vs 52/192 = 27.08%, Fishers' exact test; P = 0.02).
Two regions on chromosome 6 were initially identified, but one (6q27) was completely eliminated when SNPs were deleted for LD and rare allele frequency (seven close SNPs were dropped from this region). The 6q2.32-q24.1 just missed the suggestive linkage evidence threshold (HLOD = 1.81).
The relatively broad chromosome 7q31.31-q32.3 peak was in a region implicated by several earlier studies [42] [43] [44] [45] and maintained suggestive linkage evidence even after LD screening. No significant phenotypic differences were found among affected subjects in families supporting this peak (see Supplementary  Table 1 ).
The narrower chromosome 13q12.11-q12.3 peak also exceeded the suggestive linkage evidence threshold even after eliminating SNPs in LD. For this peak, we again did not find evidence for significant phenotypic subgroups (Supplementary Table 1 ). The peaks on chromosomes 19q13.43 and 21q22.12-q22.13 both disappeared when SNPs in LD were eliminated (10 SNPs from each location).
In an earlier linkage screen of a single large Utah family, our group previously reported regions with at least suggestive linkage evidence on chromosomes 3q13.2-q13.31, 3q26.31-q27.3, 7p14.1-p11.22, 9p24.3 and 20q11. 21-q13.12. 7 The current sample includes this original pedigree, but these regions were not strongly supported by the new pedigrees. Within these 70 pedigrees, our strongest signals in any of these earlier regions were on chromosomes 9p24.3 (HLOD = 1.30 at 2 202 546 bp) and 20q11.21-q13.12 (HLOD = 1.23 at 40 018 916 bp), but both of these regions were below the suggestive linkage threshold. The seven affected subjects in this original pedigree were notably heterogeneous across the phenotypes, though all were male individuals. An investigation of the pedigrees supporting the peaks in the current sample on chromosomes 9 and 20 showed 13% female individuals in families supporting chromosome 9 and 21% female individuals in families supporting chromosome 20. These results suggest that sex is not a defining phenotype of these linkage regions in our families.
Discussion
We have performed a genome-wide linkage scan on a large collection of families with two or more cases of ASD. The 70 families studied here, which included 26 large extended pedigrees and 44 smaller two-or three-generation pedigrees, represent 20 years of recruiting and ascertaining ASD cases in Utah. Our study is noteworthy for the significant linkage evidence observed on chromosome 15 in possibly three distinct regions and for suggestive evidence on chromosomes 2, 7 and 13. Although we observed genetic heterogeneity within the families we studied, our large extended pedigree design offers a unique resource for finding linked chromosomal regions. Nonparametric scores showed consistency with the model-based analyses, though the magnitudes of the peaks were reduced. This reduction in significance is not surprising, given multiple lines of evidence confirming the reduced statistical power of nonparametric linkage (NPL) methods. [27] [28] [29] [30] [31] [32] The consistency of the NPL results supports our choice of the HLOD statistic, which is robust to model misspecification. 28, 30 Our most significant finding was on chromosome 15q, which may comprise three separate peaks. Our 15q13.1-q14 linkage peak overlaps a region of chromosomal anomalies at 15q11-q13 implicated in autism across numerous studies. 4, 45 However, genes of primary interest reported in these other studies are primarily centromeric (20 500 000-25 000 000 bp) to the start of our linkage peak at 27 440 000 bp. A recent multicenter study by Liu et al. 46 of subjects with ASD who had IQ scores X70 reported an LOD score of 4.01 at chromosome 15q13.3-14, which overlaps the reported linkage findings in our sample. In our sample, the proportion of IQ scores > 70 from the affected subjects contributing to this peak did not differ from the proportion > 70 in our full sample. Although Utah collaborated in the Liu et al. 46 multicenter study, there was no overlap of subjects between that study and the current study.
The chromosome 15q21.2-q22.1 region in this study replicates linkage findings reported by Szatmari et al. 47 on a large sample of over 1400 multiplex families with ASDs. Szatmari et al. 47 identified an extended region from 56 600 000 to 87 500 000 bp, with two maxima: LOD = 3.19 at rs1372828 (69 302 220) and LOD = 3.41 at rs1433452 (85 395 878). These findings were strongest when subjects with copy number variations (CNVs) were removed from the analysis. The International Molecular Genetic Study of Autism Consortium (IMGSAC) also found evidence for linkage on chromosome 15q21-22 when male-male sib pairs were omitted. 48 In contrast to Lamb et al., 48 the sex ratio of our affected subjects supporting this peak did not differ from the sex ratio in our overall sample.
Consistent with the complex landscape of autism genetics, our linkage peaks on chromosome 15 showed within-and across-family heterogeneity. No individual pedigree LOD score in any large extended pedigree suggested sharing of a single haplotype across all affected cases, reinforcing the concept that genetic heterogeneity exists within individual pedigrees. Pedigrees providing the most support for the chromosome 15 peaks did not differ from the overall sample in terms of diagnostic severity, sex, IQ, language delay or ADI domain score. Further characterization of individual cases that share common haplotypes within and across pedigrees may reveal additional insights into ASD predisposition genes in the region.
Other regions with suggestive positive results in our families occurred on chromosomes 2, 7 and 13. Our chromosome 2p25.3-p24.1 findings are more telomeric than the commonly reported chromosome 2p15-p16 autism region. 4, 49, 50 In particular, the neurexin 1 gene (NRXN1), which has shown association with autism, 47, 50 is at approximately 50 000 000 bp, well downstream of our peak. Our chromosome 7q31.31-q32.3 peak overlaps earlier linkage findings reported in many studies. 42, [51] [52] [53] [54] Several interesting gene associations with autism can be found in this region, including reelin (RELN), Ca þ -dependent activator protein for secretion 2 (CADPS2) and met proto-oncogene (MET). [55] [56] [57] [58] [59] [60] [61] Finally, our chromosome 13q12.11-q12.3 peak does not appear to overlap with the 13q21 peak for autism and specific language impairment reported in several studies. [62] [63] [64] The neurobeachin gene (NBEAL2), reported to be disrupted in autism, 65 is located at 34 633 887 bp, somewhat downstream of our linkage region (21 190 000-30 950 000 bp).
Our expanded pedigree sample did not strongly support regions we reported earlier in a single extended Utah autism pedigree. Our best signals in our current data within these earlier regions were on chromosomes 9p24.3 (HLOD = 1.30) and 20q11.21-q13.12 (HLOD = 1.23), but neither of these peaks reached suggestive evidence for linkage. Affected subjects in families supporting these peaks did not share phenotypic similarity with the original family. However, families need not be phenotypically similar, even if they share the same predisposing alleles. Pleiotropy, effects of other susceptibility loci, effect of genetic background and environmental factors could all modify phenotype. The phenotypic heterogeneity and lack of strong support of original peaks is perhaps not surprising. Even in our original study, heterogeneity (genetic and phenotypic) was found within the single pedigree. Simulation analyses in our original study showed that those findings were not likely to be false positives, but our new results suggest that these predisposing alleles are not common among our other pedigrees.
In conclusion, our results implicate a region on chromosome 15 that replicates results published by others and may harbor one or more susceptibility genes for autism. Although this region overlaps with peaks from earlier studies, specific genes have not yet been identified and will require more detailed molecular work. To date, our investigation of phenotypes in families supporting the linkage evidence has not revealed consistent subtypes, though these analyses have only focused on very broad aspects of the ASD phenotype. More detailed analyses of additional aspects of phenotype, including presence of seizures, verbal ability and other aspects of the clinical phenotype, are planned. These results can be used to direct future gene-localization efforts. the National Center for Research Resources. Partial support for all data sets within the Utah Population Database (UPDB) was provided by the University of Utah Huntsman Cancer Institute. We thank our staff whose countless hours of work have made this study possible. We also greatly appreciate the time and effort given by the family members who participated in this study.
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